Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

NCT00308425 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

De Novo Renal Transplantation

Interventions

DRUG: Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Sponsor

Novartis